Healthcare >> CEO Interviews >> October 5, 2000
DR. SPENCER B. FARR is the CEO and Founder of PHASE-1 Molecular
Toxicology, Inc. He was a member of the scientific advisory board to the
U.S. Food and Drug Administration during 1998 and 1999. Dr. Farr
currently serves on the editorial board of In Vitro Toxicology, Genetic
Engineering News, and Toxicological Sciences and the grant review
committees of the American Cancer Society, National Institutes of Health
and National Science Foundation. He was an Assistant Professor in the
Department of Cellular and Molecular Toxicology at the Harvard School of
Public Health and a member of the Center for Environmental Health
Sciences at the Massachusetts Institute of Technology. Dr. Farr received
his Bachelor of Science degree in Genetics from the University of
California at Berkeley and his PhD from the University of New Mexico
School of Medicine and the Institut Jacques Monod, Paris, France. Profile
Toxicology?
Dr. Farr: There are three fundamental problems with the way that
toxicology is performed today for drug development '
